DUBLIN, April 25, 2022 (GLOBE NEWSWIRE) — The Ophthalmic Implants Market – Global Outlook & Forecast 2022-2027 report has been added ResearchAndMarkets.com Offer.
The ophthalmic implant market size is expected to grow at a CAGR of 6.5%.
Intraocular lenses are expected to register the highest incremental growth and glaucoma implants the highest absolute growth during the forecast period. Rising cases of presbyopia, myopia, blindness, cataract surgery and farsightedness are expected to boost demand for the global eye implant market.
Other important reasons behind the growth of the market are the increasing awareness of comprehensive ophthalmic services, the increase in the geriatric population and the inclusion of ophthalmic services in the insurance system. The total number of patients undergoing cataract surgery has more than tripled in a decade, a key factor that has impacted intraocular lens industry players.
Hospitals are expected to witness the highest incremental growth over the forecast period. The hospital segment is the dominant segment in the ophthalmic implant market. Glaucoma drain implantation is performed in an outpatient surgery center or hospital.
The increasing aging of the population and rising awareness in the North American region is expected to drive the ophthalmic implant market size in the region.
Advances in ophthalmic diagnostic technology have led to broader product acceptance. The easy accessibility of online tools has enlightened the public about different treatment options and will help the market to grow. The increasing acceptance of advanced ocular devices such as artificial eyes and glaucoma devices has opened up the potential for companies operating in the market.
The increasing number of regulatory approvals for corneal implants will help large companies to generate significant revenue from the ocular implant market in the years to come.
The emergence of various advanced intraocular lenses and increasing competition among manufacturers to develop better lenses, as well as an increase in investment in eye research institutes by governmental and non-governmental organizations are expected to boost the market growth.
OPPORTUNITIES FOR MARKET GROWTH
- Growing advances in ophthalmic diagnostic technology
- Increasing acceptance of advanced eyepiece devices
- Increase in the number of cases of eye diseases
- Raising awareness of the diagnosis and treatment of eye diseases
- Product launches and approvals to increase market share
- In May 2020, the launch of the presbyopia-correcting intraocular lens (IOL) LuxSmart and its monofocal version LuxGood was announced. Both come with pre-installed delivery systems and Pure Refractive Optics (PRO) technology.
- In January 2021, the AcrySof IQ Vivity IOL (Vivity), the extended depth of field (IOL) non-diffractive intraocular lens, was launched in the United States. Vivity is used in the AcrySof IQ IOL.
- Bausch & Lomb
Other prominent providers
- second look
- microtechnical solutions
- Gulden Ophthalmic
- AJL Ophthalmic SA
- EyeD Pharma
- care group
- F. Ad. Müller Sons GmbH & Co. KG
- Hoya Corporation
- Morcher GmbH
- Ophtec B.V
- Rayner Intraocular Lenses Limited
- Glaukos Corporation
- CorNeat Vision
- omni lens
- POLYACTIVA PTY LTD
- LAMBDA VISION
- SMR Ophthalmology PVT. GMBH
- Labtician Ophthalmics, Inc
- Divine Meditech
- iSTAR Medical
Main topics covered:
1 research methodology
2 research goals
3 research process
4 Scope and Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study
5 Report assumptions and reservations
5.1 Important caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a glance
7.2 Effects of Covid-19
8 Market Opportunities and Trends
8.1 Rise of artificial intelligence to detect diabetic retinopathy
8.2 Use of artificial corneal implants
8.3 Increase in the use of robotic surgical assistants for eye surgeries
9 Market Growth Promoters
9.1 Increasing Advances in Ophthalmic Diagnostic Technology
9.2 Increasing acceptance of advanced eyepiece devices
9.3 Increase in the number of cases of eye diseases
9.4 Raising awareness of the diagnosis and treatment of eye diseases
9.5 Increase in preference for minimally invasive eye surgery
10 Market Restrictions
10.1 Strict Regulatory Approvals and Product Recalls
10.2 Increasing the risk of surgical failure
11 market landscape
11.1 Market Overview
11.2 Market Size and Forecast
11.3 Five Force Analysis
12.1 Market Overview and Growth Engine
12.2 Market Overview
12.3 Intraocular lenses
12.4 Glaucoma implants
12.5 Corneal Implants
13.1 Market overview and growth engine
13.2 Market Overview
13.3 Cataract surgery
13.4 Glaucoma Surgery
14 end users
14.1 Market overview and growth engine
14.2 Market Overview
14.4 Ambulatory Surgery Centers
14.5 Eye Clinics
15.1 Market overview and growth engine
15.2 Geographical Overview
For more information about this report, visit https://www.researchandmarkets.com/r/95pm2u